Cannabinoid benefits / Cannabidiol cbd oil benefits


You may be thinking, “what are the benefits of CBD oil on my health?” In recent years, CBD oil has been the deliberation of many research studies across the world. There are many studies highlighting the positive effects of CBD oil as a treatment for health conditions such as epilepsy, chronic pain, cancer, depression, Alzheimer’s and many others. There has been extensive research since the CB1 and CB2 receptors were discovered to bind with cannabis cannabinoids.

The endo-cannabinoid system consists of a network of receptors (CB1 and CB2) in the body that bind with cannabinoids. It has been discovered that cannabinoids are produced within the body but another source of cannabinoids is the marijuana plant. The marijuana plant consists of over 80+ cannabinoids and the prominent two within the plant are (THC) and cannabidiol (CBD). It is believed CBD acts as an antagonist against both CB1 and CB2 receptors, therefore inhibiting the physiological action of unhealthy cells that bind to these receptors.

CBD oil has been found to have a positive effect on the condition epilepsy. Research has shown that CBD oil benefits people and children with severe forms of epilepsy by reducing seizures. Many studies have demonstrated positive outcomes with patients taking CBD oil with less than 0.3% THC. 60% of children achieved a reduction of 50+% in the number of seizures they experienced. 10% of children became seizure free after consuming the CBD in oil form.

Early research studies have shown CBD Oil can have a positive effect on the fight against cancer. Tests have indicated cannabis may aid current treatment methods and even destroy the walls of cancer cells. Research into CBD has shown it inhibits cell growth of human carcinoma breast cells. CBD has shown to support current treatment of chemotherapy by reducing nausea, pain, indigestion, and increasing appetite.

The brain is comprised of CB1 receptors and the euphoric effects of THC are caused by its activation of these CB1 receptors. When CBD binds to these CB1 receptors it produces little to no effect because CBD has a very low affinity to CB1 receptors. This is major reason why CBD has shown to have a positive effect on depression, Alzheimer’s and other neurological diseases. Many people that take CBD Oil on a regular basis experience clarity in thoughts and emotions and feel revitalised.




A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists, Vincenzo Di Marzo, Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, TRENDS in Pharmacological Sciences. 01.10.2006, Review, Science Direct.

Welty et al. Cannabidiol: promise and pitfalls. Epilepsy Curr. 14(5):250-2. (2014).

Porter BE and Jacobson C. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy & Behavior 29 (2013) 574–577.

Press et al. Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy & Behavior 45 (2015) 49–52.

Hussain et al. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome. Epilepsy Behav. 2015 Apr 29. pii: S1525-5050(15)00157-2.

Gloss and Vickrey B. Cannabinoids for epilepsy. Cochrane Database Syst Rev. 3:CD009270. (2014).

Martín-Moreno et al. Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer’s Disease. Molecular Pharmacology. 79(6):964-973. (2011).

Bergamaschi et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology 2011;36:1219–1226.

Nora D. Volkow et al, The Biology and Potential Therapeutic Effects of Cannabidiol. 2015 June 24

Sean D.McAllister et al. Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. 2004

Ward SJ et al. Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy. 2014 feb, 171(3); 636-45.

KATHERINE ANN SCOTT et al. Enhancing the Activity of Cannabidiol and Other Cannabinoids In VitroThrough Modifications to Drug Combinations and Treatment Schedules. Anti Cancer research. 2013 Oct, vol 33.

Moreno et al. Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.. 2014 aug 8; 289(32):21960-72.

Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br J Pharmacol. 2008 Jan; 153(2): 199–215.

Martin-Santos et al. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. Curr Pharm Des. 2012;18(32):4966-79.

Fusar-Poli et al. Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing. Arch Gen Psychiatry. 2009;66(1):95-105

Winton-Brown et al. Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study. Neuropsychopharmacology. 2011 Jun;36(7):1340-8.

Bergamaschi et al. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf. 2011 Sep 1;6(4):237-49.

Neelakantan et al. Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice. Behav Pharmacol. 26(3):304-14. (2015).

McAllister et al. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids. J Neuroimmune Pharmacol. 2015 Apr28.

McAllister et al. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids. J Neuroimmune Pharmacol. 2015 Apr28.

Massi et al. 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. J Neurochem. 2008 Feb;104(4):1091-100.

Wilkinson et al. Impact of Cannabis Use on the Development of Psychotic Disorders. Curr Addict Rep. 2014 Jun 1;1(2):115-128.

Iseger and Bossong. A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophr Res. 162(1-3):153-61. (2015).

Guimaraes et al. Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology (Berl) 100:558–559 (1990).

Lemos et al. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats. Behav Brain Res 207:105–111(2010).

Das et al. Cannabidiol enhances consolidation of explicit fear extinction in humans. Psychopharmacology (Berl). 2013 Apr;226(4):781-92.

Campos et al. Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats. Psychopharmacology (Berl). 2013 Mar;226(1):13-24.

Katsidoni et al. Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus. Addict Biol. 2013;18(2):286–96.

Ren et al. Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances. J Neurosci. 2009;29(47):14764–9.

Sign up

Get 10% off your first order

Stay up to date with our lastest news and products

Please confirm you would like to receive marketing emails about CBD oil Products